Promoter CA Hull Investments sold 2.56 crore shares of Viyash Scientific for approximately ₹685 crore through the open market, reducing its stake from 31.17% to 25.31%.
A leading animal health company headquartered in India, this organization develops and manufactures finished dose formulations, active pharmaceutical ingredients, and analytical services for the pharmaceutical and life sciences sectors. Operating across more than 100 countries spanning five continents, the company serves veterinary and industrial clients globally with a comprehensive product portfolio designed for animal health applications and therapeutic solutions.
Get the next move the moment it happens.
Follow the investors and Viyash Scientific Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.